Michael Wayne Kalb insider trades

Open-market stock purchases and sales by Michael Wayne Kalb, Chief Financial Officer at Catalyst Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 1, 2016.

Recent trades

DateStockTradeValue
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)$430K
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jul 15, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jan 5, 2026CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Jan 5, 2026CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncSold (not open market)—
Nov 21, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—
Nov 20, 2025CPRX Catalyst Pharmaceuticals, IncBought (not open market)—

Companies traded

  • CPRX Catalyst Pharmaceuticals, Inc: other filings, last Jul 15, 2026
  • IMPL Impel Pharmaceuticals Inc: other filings, last May 10, 2023
  • CINC CinCor Pharma, Inc: other filings, last Feb 24, 2023
  • AMRN Amarin Corp Plc\uk: 14 sales, last Aug 1, 2022

Get free alerts when Michael Wayne Kalb files a new trade →